Cyclacel Pharma
CYCC----
Q2 FY2025 Earnings
Financial report interval: 2025.03.30 - 2025.06.30
Overview: Cyclacel Pharma(CYCC) the EBIT is -1.317 M (+63.86%);the EPS is -1.53 (--%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B63.86%
----
----
EPS
-1.5275--
----
----
Revenue
ActualEstimateUnit: USD
Quarterly
EBIT
ActualEstimateUnit: USD
Quarterly
Net income
ActualEstimateUnit: USD
Quarterly
EPS
ActualEstimateUnit: USD
Quarterly